The ThrombiDisc
™ Topical Hemostat is
applied topically as an
adjunct to manual compression and is indicated for the control of
surface bleeding from vascular
access sites and percutaneous catheters or tubes.
ThrombiDisc
™ Topical Hemostat
contains silver chloride to prevent microorganisms commonly encountered
in the clinical setting
from colonizing on the pad.
The ThrombiDisc
™ Topical Hemostat is contraindicated in
persons with known
sensitivity to bovine-derived materials.
WARNING: SEVERE
BLEEDING AND THROMBOSIS COMPLICATIONS
- THROMBIN-JMI® can cause fatal severe bleeding or
thrombosis. Thrombosis may
result from the development of antibodies against bovine thrombin.
Bleeding may result from the
development of antibodies against factor V. These may cross-react
with human factor V and lead
to its deficiency.
- Do not re-expose patients to THROMBIN-JMI® if there
are known or suspected
antibodies to bovine thrombin and/or factor V.
- Monitor patients for abnormal coagulation laboratory values,
bleeding, or thrombosis.
*The clotting time of whole blood without the addition of any patch was
used as a control.
Refer to the Instructions for Use for a complete listing of the
indications, contraindications,
warnings and precautions. Information in this material is not a
substitute for the product
Instructions for Use.
CAUTION: Federal (USA) law restricts this device to sale by or on the
order of a physician.
THROMBIN-JMI is a registered trademark of King Pharmaceuticals Research
and Development, LLC.
Teleflex, the Teleflex logo and ThrombiDisc are trademarks or registered
trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries.
MC-005114
